慢性病和高尿血症患者的尿酸降低疗法和结结果
Sheng Nie1, Shiyu Zhou1, Ruixuan Chen1
1State Key Laboratory of Multiorgan Injury Prevention and Treatment, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, National Clinical Research Center for Kidney Disease, Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Signal transduction and targeted therapy
|December 8, 2025
概括
尿酸降低疗法 (ULT) 在患有慢性病 (CKD) 和高尿血症的患者中显著降低病进展和死亡率. 需要进一步的研究来证实这些发现在大型临床试验中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 超尿血是慢性病 (CKD) 进展的可修改风险因素.
- 尿酸降低疗法 (ULT) 对慢性病患者结局的影响仍然存在争议.
- 需要证据来指导ULT在治疗高尿血症的CKD中的使用.
研究的目的:
- 为了评估ULT与单独的支持性护理相比,ULT在患有CKD和高尿血症的患者中对脏结果的有效性.
- 评估ULT对复合结局,末期病 (ESKD) 和死亡率的影响.
- 为临床决策提供证据,关于在CKD管理中ULT.
主要方法:
- 一个使用顺序目标试验仿真框架的队列研究.
- 包括来自中国脏数据系统的269,831个人试验 (56,936个独特人) 患有慢性脏病和高尿血症.
- 主要结局:综合性结局 (≥40%的EGFR下降或ESKD).
主要成果:
- 复合结结果的3年累计发病率在ULT组 (19.69%) 与对照组 (23.22%) 相比,在ULT组较低.
- ULT与显著降低ESKD风险,所有原因死亡率和心血管死亡率有关.
- 亚组和敏感性分析证实了ULT的这些有益影响.
结论:
- 在患有第三阶段或更高的CKD和高尿血症的患者中,ULT与病进展和死亡率的风险明显降低.
- 这些发现表明,ULT对治疗尿酸水平升高的CKD患者有益.
- 需要进一步进行大型随机临床试验,以确定ULT在该人群中的作用.
相关概念视频
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
196
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
196
01:16Antihypertensive Drugs: Action of Diuretics
2.2K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.2K
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
339
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
339
01:20Acute Kidney Injury V: Interprofessional Care
282
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
282
01:28Chronic Kidney Disease III: Interprofessional Care
323
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
323
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K